| David F. Hale |
Mr. David F. Hale is a Chairman at Adigica Health, Inc., a Chairman at Recros Medica, Inc., an Executive Chairman at MDRejuvena, Inc., a Chairman at Agility Clinical, Inc., a Non-Executive Chairman at Biocept, Inc., a Chairman at Advantar Laboratories, Inc., a Chairman at Conatus Pharmaceuticals, Inc., a Chairman at Hale BioPharma Ventures LLC, an Advisor at Windamere Venture Partners LLC, a Chairman at Clarify Medical, Inc., a Chairman at Intrepid Therapeutics, Inc., a Chairman at Oncternal Therapeutics, Inc., a Chairman at Rady Children's Institute for Genomic Medicine, a Chairman at Rich Diagnostics, Inc., a Chairman at Ridge Diagnostics, Inc., an Executive Chairman at Neurana Pharmaceuticals, Inc. and a General Partner at Hale Trading Co. LP. He is on the Board of Directors at Neurelis, Inc., BIOCOM, Dermata Therapeutics LLC, Idun Pharmaceuticals, Inc., San Diego Regional Economic Development Corp., Rady Children's Hospital & Health Center of San Diego and The Salk Institute for Biological Studies. |
| Alfred P. Spada |
Founder of Conatus Pharmaceuticals, Inc., Alfred P. Spada is Chief Scientific Officer, EVP-R&D at this company.
In the past he was Department Director at Aventis Pharmaceuticals, Inc., Department Director at Rhone Poulenc AG, Inc., Principal at Rorer Pharmaceuticals, Inc. and VP-Pharmaceutical & Preclinical Development at Idun Pharmaceuticals, Inc.
Alfred P. Spada received an undergraduate degree from Worcester Polytechnic Institute and a doctorate from Massachusetts Institute of Technology. |
| Keith W. Marshall |
Founder of Montgomery, Marshall Healthcare Partners LLC, Keith W. Marshall is Executive VP, Chief Operating & Financial Officer at Conatus Pharmaceuticals, Inc.
He previously occupied the position of Chief Financial Officer & Managing Director at Montgomery, Marshall Healthcare Partners LLC, CFO & Head-Corporate Development at Torque Therapeutics, Inc., Managing Director-Healthcare Investment Ban at TAG Healthcare Advisors LLC, Research Associate at ImmuLogic Pharmaceutical Corp., Associate-Healthcare Investment Banking at JPMorgan H&Q Principals LP, Managing Director-Healthcare Investment Banking at Montgomery & Co. and Managing Director at Sagent Advisors LLC.
Dr. Marshall received an MBA from The University of Chicago, a doctorate from the University of California and an undergraduate degree from the University of Washington. |
| Steven J. Mento |
Steven J. Mento founded Conatus Pharmaceuticals, Inc. Presently, he is President, Chief Executive Officer & Director at this company. Dr. Mento is also on the board of BIOCOM, BIO Emerging Co. and Donald P. Shiley Bioscience Center and Director & Member-Health Section at Biotechnology Innovation Organization.
Dr. Mento previously held the position of Director-Viral Vaccine Research & Development at Lederle Praxis Biological, Inc., President, Chief Executive Officer & Director at Idun Pharmaceuticals, Inc., Vice President-Research & Development of Chiron Viagene, Inc., Vice President-Research & Development for Chiron Viagene, Inc., Vice President-Research & Development for Chiron Corp. and Assistant Research Professor at Icah School of Medicine at Mount Sinai.
Dr. Mento received a doctorate, a graduate degree and an undergraduate degree from Rutgers State University of New Jersey. |
| Harold E. van Wart |
Harold E. van Wart is on the board of Idun Pharmaceuticals, Inc. and Conatus Pharmaceuticals, Inc.
In the past he was Chairman of California Biomedical Innovation Alliance and Chairman for The Bay Area Bioscience Association (a subsidiary of California Biomedical Innovation Alliance), President, Chief Executive Officer & Director at CymaBay Therapeutics, Inc., Vice President & Head-Therapy-Roche Bioscience at Syntex Corp. and Faculty Member at Florida State University.
He received a doctorate from Cornell University and an undergraduate degree from State University of New York at Binghamton. |
| Kathleen D. Scott |
Kathleen D. Scott is on the board of Conatus Pharmaceuticals, Inc. and YMCA of San Diego County and Managing Director at Hale BioPharma Ventures LLC.
She previously was Chief Financial Officer of FeRx, Inc., Chief Financial Officer & Director at BioSurplus, Inc., Partner at RA Capital Advisors LLC, Auditor for Arthur Andersen LLP and Member of The Phi Beta Kappa Society.
Kathleen D. Scott received an undergraduate degree from the University of California, Los Angeles. |
| William R. LaRue |
Mr. William R. LaRue is an Independent Director at Conatus Pharmaceuticals, Inc. and an Independent Director at TRACON Pharmaceuticals, Inc. He is on the Board of Directors at ALASTIN Skincare, Inc., Oncternal Therapeutics, Inc., Conatus Pharmaceuticals, Inc. and TRACON Pharmaceuticals, Inc. Mr. LaRue was previously employed as a CFO, Treasurer, Director & Senior VP by Cadence Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by Amgen Rockville, Inc., a Chief Financial Officer & Senior VP by CancerVax Corp., a Chief Financial Officer & Executive Vice President by eHelp Corp., a Treasurer & Vice President by Safeskin Corp., and a Treasurer by GDE Systems, Inc. He also served on the board at Oncternal Oncology, Inc., Applied Proteomics, Inc. and Neurelis, Inc. He received his undergraduate degree from the University of Southern California and an MBA from the University of Southern California. |
| Preston S. Klassen |
Presently, Preston S. Klassen occupies the position of Executive VP, Head-Research & Development at Arena Pharmaceuticals, Inc. and President for Sanifit, Inc. Dr. Klassen is also on the board of Conatus Pharmaceuticals, Inc.
Dr. Klassen previously was President & Chief Medical Officer at Sanifit Therapeutics SA, Executive Director-Medical at Amgen, Inc. and Executive Vice President-Global Development at Orexigen Therapeutics, Inc.
He received a doctorate from the University of Nebraska Medical Center and a graduate degree from Duke University. |
| Daniel L. Kisner |
Daniel L. Kisner is a businessperson who has been the head of 7 different companies and currently is Chairman for Idun Pharmaceuticals, Inc. He is also on the board of 6 other companies.
In the past Dr. Kisner occupied the position of Chairman for Arbutus Biopharma Corp., Chairman at Caliper Technologies Corp., Chairman for Avera Pharmaceuticals, Inc., Chairman for Sequoia Pharmaceuticals, Inc., President & Chief Operating Officer for Ionis Pharmaceuticals, Inc., Partner at Aberdare Ventures, Vice President-Pharmaceutical Development at Abbott Laboratories, Chairman for Caliper Life Sciences, Inc. and Vice President-Clinical Research & Development at Smithkline Beckman Corp.
Daniel L. Kisner received a doctorate from Georgetown University and an undergraduate degree from Rutgers State University of New Jersey. |
